Enter your keyword

8053+ OFFICERS SERVING THE NATION UNIVERSAL COACHING CENTRE Let's join hands together in bringing Your Name in Elite officers list. JOIN US 25 YEARS OF EXCELLENCE MEET NEW FRIENDS AND STUDY WITH EXPERTS JOIN US Nothing is better than having friends study together. Each student can learn from others through by teamwork building and playing interesting games. Following instruction of experts, you and friends will gain best scores.

ULP Click here! Click here! Classroom Programme NRA-CET Test Series
Click here ! Org code: XSHWV

post

ZIMBABWE ROLLS OUT LONG-ACTING HIV PREVENTION DRUG LENACAPAVIR

Why in the News?

  • Public Health Initiative: Zimbabwe has launched rollout of long-acting injectable HIV prevention drug lenacapavir.
  • Global First Mover: It is among the first countries offering a twice-yearly injectable HIV preventive treatment

 

LENACAPAVIR AND HIV PREVENTION STRATEGY

  • Long-Acting Protection: Lenacapavir provides six months’ HIV prevention through a biannual injectable regimen, improving adherence compared to daily pills.
  • Target Population: Initial phase targets 46,500 high-risk individuals, including young women and pregnant or breastfeeding mothers.
  • Free Provision: Drug is offered free to vulnerable groups, ensuring equitable access to preventive healthcare services.
  • Pharmaceutical Development: The medicine is developed by Gilead Sciences, highlighting role of private sector innovation in global health.
  • Global Partnerships: Rollout supported through PEPFAR and the Global Fund, demonstrating multilateral cooperation in disease control.

PUBLIC HEALTH AND POLICY IMPLICATIONS

  • Infection Control: Long-acting prophylaxis could significantly reduce new HIV infections, particularly in high-burden African nations.
  • Adherence Advantage: Reduced dosing frequency addresses challenges of treatment compliance and stigma-related discontinuation.
  • Maternal Health Linkage: Inclusion of pregnant and breastfeeding women strengthens mother-to-child transmission prevention efforts.
  • Health Financing Model: International donor support reflects continued reliance on global health financing mechanisms.
  • Equity Focus: Targeted prevention strategy aligns with principles of universal health coverage and vulnerable population protection.

HIV/AIDS PREVENTION AND GLOBAL HEALTH GOVERNANCE

  HIV Burden: Sub-Saharan Africa remains disproportionately affected by HIV/AIDS, requiring sustained prevention strategies.

  Preventive Tools: Pre-exposure prophylaxis (PrEP) and long-acting injectables complement antiretroviral therapy frameworks.

  Global Institutions: Initiatives like PEPFAR and the Global Fund play central roles in combating infectious diseases.

  Public Health Strategy: Effective HIV control integrates prevention, testing, treatment, and community outreach mechanisms.

  UPSC Relevance: Topic relates to GS Paper II and III, covering health policy, international cooperation, and disease management strategies